183 related articles for article (PubMed ID: 31953902)
1. Kaposi sarcoma among people living with HIV in the French DAT'AIDS cohort between 2010 and 2015.
Poizot-Martin I; Obry-Roguet V; Duvivier C; Lions C; Huleux T; Jacomet C; Ferry T; Cheret A; Allavena C; Bani-Sadr F; Palich R; Cabié A; Fresard A; Pugliese P; Delobel P; Lamaury I; Hustache-Mathieu L; Brégigeon S; Makinson A; Rey D;
J Eur Acad Dermatol Venereol; 2020 May; 34(5):1065-1073. PubMed ID: 31953902
[TBL] [Abstract][Full Text] [Related]
2. No increased risk of Kaposi sarcoma relapse in patients with controlled HIV-1 infection after switching protease inhibitor-based antiretroviral therapy.
Lajaunie R; Cuzin L; Palich R; Makinson A; Bani-Sadr F; Duvivier C; Arvieux C; Rey D; Poizot-Martin I; Delpierre C; Delobel P; Martin-Blondel G;
HIV Med; 2022 Mar; 23(3):301-306. PubMed ID: 34668293
[TBL] [Abstract][Full Text] [Related]
3. Kaposi sarcoma in people living with HIV: incidence and associated factors in a French cohort between 2010 and 2015.
Poizot-Martin I; Lions C; Cheret A; Rey D; Duvivier C; Jacomet C; Allavena C; Huleux T; Bani-Sadr F; Obry-Roguet V; Makinson A;
AIDS; 2020 Mar; 34(4):569-577. PubMed ID: 31764070
[TBL] [Abstract][Full Text] [Related]
4. Immune reconstitution inflammatory syndrome associated with Kaposi sarcoma: higher incidence and mortality in Africa than in the UK.
Letang E; Lewis JJ; Bower M; Mosam A; Borok M; Campbell TB; Naniche D; Newsom-Davis T; Shaik F; Fiorillo S; Miro JM; Schellenberg D; Easterbrook PJ
AIDS; 2013 Jun; 27(10):1603-13. PubMed ID: 23462220
[TBL] [Abstract][Full Text] [Related]
5. Kaposi sarcoma-associated herpesvirus, HIV-1 and Kaposi sarcoma risk in black South Africans diagnosed with cancer during antiretroviral treatment rollout.
Motlhale M; Muchengeti M; Bradshaw D; Chen WC; Singini MG; de Villiers CB; Lewis CM; Bender N; Mathew CG; Newton R; Waterboer T; Singh E; Sitas F
Int J Cancer; 2023 May; 152(10):2081-2089. PubMed ID: 36727526
[TBL] [Abstract][Full Text] [Related]
6. Comparison of Kaposi Sarcoma Risk in Human Immunodeficiency Virus-Positive Adults Across 5 Continents: A Multiregional Multicohort Study.
AIDS-defining Cancer Project Working Group for IeDEA and COHERE in EuroCoord
Clin Infect Dis; 2017 Oct; 65(8):1316-1326. PubMed ID: 28531260
[TBL] [Abstract][Full Text] [Related]
7. A prospective cohort study identifies two types of HIV+ Kaposi Sarcoma lesions: proliferative and inflammatory.
Moorad R; Kasonkanji E; Gumulira J; Gondwe Y; Dewey M; Pan Y; Peng A; Pluta LJ; Kudowa E; Nyasosela R; Tomoka T; Tweya H; Heller T; Gugsa S; Phiri S; Moore DT; Damania B; Painschab M; Hosseinipour MC; Dittmer DP
Int J Cancer; 2023 Dec; 153(12):2082-2092. PubMed ID: 37602960
[TBL] [Abstract][Full Text] [Related]
8. Incident Kaposi sarcoma during the expansion of antiretroviral therapy eligibility in Nigeria: a retrospective cohort study.
Akanbi MO; Bilaver LA; Achenbach C; Hirschhorn LR; Rivera AS; Adekolujo OS; Adekola KUA; Silas OA; Agaba PA; Agbaji O; Shehu NY; Sagay SA; Hou L; Murphy RL
BMC Cancer; 2023 Sep; 23(1):890. PubMed ID: 37735371
[TBL] [Abstract][Full Text] [Related]
9. Treatment of Kaposi sarcoma in children with HIV-1 infection.
Anglemyer A; Agrawal AK; Rutherford GW
Cochrane Database Syst Rev; 2014 Jan; (1):CD009826. PubMed ID: 24464843
[TBL] [Abstract][Full Text] [Related]
10. Impact of Protease Inhibitors on HIV-Associated Kaposi Sarcoma Incidence: A Systematic Review.
Chang E; Mapakshi SR; Mbang P; El-Mallawany NK; Kramer JR; White DL; Chiao EY
J Acquir Immune Defic Syndr; 2018 Oct; 79(2):141-148. PubMed ID: 29985803
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of plasma human herpesvirus 8 DNA as a marker of clinical outcomes during antiretroviral therapy for AIDS-related Kaposi sarcoma in Zimbabwe.
Borok M; Fiorillo S; Gudza I; Putnam B; Ndemera B; White IE; Gwanzura L; Schooley RT; Campbell TB
Clin Infect Dis; 2010 Aug; 51(3):342-9. PubMed ID: 20572760
[TBL] [Abstract][Full Text] [Related]
12. AIDS-associated Kaposi sarcoma: outcomes after initiation of antiretroviral therapy at a university-affiliated hospital in urban Zimbabwe.
Nelson BC; Borok MZ; Mhlanga TO; Makadzange AT; Campbell TB
Int J Infect Dis; 2013 Oct; 17(10):e902-6. PubMed ID: 23809198
[TBL] [Abstract][Full Text] [Related]
13. Association of CD4+ T-cell Count, HIV-1 RNA Viral Load, and Antiretroviral Therapy With Kaposi Sarcoma Risk Among HIV-infected Persons in the United States and Canada.
Dubrow R; Qin L; Lin H; Hernández-Ramírez RU; Neugebauer RS; Leyden W; Althoff KN; Achenbach CJ; Hessol NA; Modur SP; DʼSouza G; Bosch RJ; Grover S; Horberg MA; Kitahata MM; Mayor AM; Novak RM; Rabkin CS; Sterling TR; Goedert JJ; Justice AC; Engels EA; Moore RD; Silverberg MJ;
J Acquir Immune Defic Syndr; 2017 Aug; 75(4):382-390. PubMed ID: 28394855
[TBL] [Abstract][Full Text] [Related]
14. Incidence rate of Kaposi sarcoma in HIV-infected patients on antiretroviral therapy in Southern Africa: a prospective multicohort study.
Rohner E; Valeri F; Maskew M; Prozesky H; Rabie H; Garone D; Dickinson D; Chimbetete C; Lumano-Mulenga P; Sikazwe I; Wyss N; Clough-Gorr KM; Egger M; Chi BH; Bohlius J
J Acquir Immune Defic Syndr; 2014 Dec; 67(5):547-54. PubMed ID: 25393941
[TBL] [Abstract][Full Text] [Related]
15. The Persistence of HIV Diversity, Transcription, and Nef Protein in Kaposi's Sarcoma Tumors during Antiretroviral Therapy.
Nolan DJ; Rose R; Zhang R; Leong A; Fogel GB; Scholte LLS; Bethony JM; Bracci P; Lamers SL; McGrath MS
Viruses; 2022 Dec; 14(12):. PubMed ID: 36560778
[TBL] [Abstract][Full Text] [Related]
16. A comparative study of classic and HIV-viremic and aviremic AIDS Kaposi sarcoma.
Séverin D; Bessaoud F; Meftah N; Du Thanh A; Tretarre B; Guillot B; Makinson A
AIDS; 2021 Mar; 35(3):399-405. PubMed ID: 33181532
[TBL] [Abstract][Full Text] [Related]
17. Use of boosted protease inhibitors reduces Kaposi sarcoma incidence among male veterans with HIV infection.
Kowalkowski MA; Kramer JR; Richardson PR; Suteria I; Chiao EY
Clin Infect Dis; 2015 May; 60(9):1405-14. PubMed ID: 25586682
[TBL] [Abstract][Full Text] [Related]
18. Isolated penile Kaposi's sarcoma in a HIV-positive patient stable on treatment for three years.
Lebari D; Gohil J; Patnaik L; Wasef W
Int J STD AIDS; 2014 Jul; 25(8):607-10. PubMed ID: 24492851
[TBL] [Abstract][Full Text] [Related]
19. Successful treatment of an HIV-positive patient with unmasking Kaposi's sarcoma immune reconstitution inflammatory syndrome.
Speicher DJ; Sehu MM; Johnson NW; Shaw DR
J Clin Virol; 2013 Jul; 57(3):282-5. PubMed ID: 23578530
[TBL] [Abstract][Full Text] [Related]
20. Long-term outcomes for children and adolescents with Kaposi sarcoma.
Silverstein A; Kamiyango W; Villiera J; Peckham-Gregory EC; McAtee CL; Scheurer ME; Cox CM; Kovarik CL; Campbell LR; Allen CE; Mehta PS; Kazembe PN; Ozuah NW; El-Mallawany NK
HIV Med; 2022 Feb; 23(2):197-203. PubMed ID: 34634187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
